Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%)
< Home < Back

Cipla’s arm acquires entire stake in Mirren

Date: 23-10-2018

Cipla’s wholly owned subsidiary -- Cipla Medpro South Africa (Pty) has completed the acquisition of 100% stake in Mirren (Pty) on October 22, 2018.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.